By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Bellicum Pharmaceuticals, Inc. 

2 Greenway Plaza
Suite 1380
Houston  Texas  77046  U.S.A.
Phone: 713-798-8670 Fax: 713-798-4950



Company News
Bellicum (BLCM) Presents Updated Clinical Results At 2017 BMT Tandem Meetings On BPX-501 In Orphan Inherited Blood Disorders And Hematologic Cancers 2/23/2017 12:32:46 PM
Bellicum (BLCM) Announces Initiation Of Patient Dosing With Controllable CAR T-Cell Product Candidate 2/21/2017 10:52:08 AM
Genentech (RHHBY)'s Oncology Boss Jumps Ship to Helm Bellicum (BLCM) 1/31/2017 5:48:20 AM
Bellicum (BLCM) Announces GoCAR-T and GoTCR Preclinical Presentations at the American Society of Hematology 2016 Annual Meeting 12/6/2016 11:54:42 AM
Bellicum (BLCM) Presents Clinical Results To Date Of BPX-501 Pediatric Program And Provides Regulatory Update At Investor Event During American Society of Hematology Annual Meeting 12/6/2016 11:32:46 AM
Bellicum (BLCM) Announces Updated Clinical Data From BPX-501 Study In Children With Primary Immune Deficiencies And Hemoglobinopathies 12/5/2016 12:02:17 PM
Bellicum (BLCM) Announces GoCAR-T And GoTCR Preclinical Presentations At The American Society of Hematology 2016 Annual Meeting 12/5/2016 11:12:42 AM
Bellicum (BLCM) Recommended For $16.9 Million Award From The Cancer Prevention And Research Institute Of Texas 11/17/2016 12:05:55 PM
Bellicum (BLCM) Reports Third Quarter 2016 Financial Results 11/10/2016 3:09:23 PM
Bellicum (BLCM) Announces Data Presentations On Lead Product Candidate BPX-501 And CAR-T And TCR Programs At The 58th American Society of Hematology Annual Meeting 11/3/2016 10:39:20 AM